Evidence map›Paper›PMID 27114440›Full record

ArticleJournal of biomaterials applications2016

Optimization of alginate purification using polyvinylidene difluoride membrane filtration: Effects on immunogenicity and biocompatibility of three-dimensional alginate scaffolds.

Hugo P Sondermeijer, Piotr Witkowski, David Woodland, Tetsunori Seki, Frank J Aangenendt, Arnoud van der Laarse, Silviu Itescu, Mark A Hardy

Open access · greenAbstract read
In one paragraph

Article in Journal of biomaterials applications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Advances in alginate biosynthesis: regulation and production inFrontiers in bioengineering and biotechnology · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Hugo P SondermeijerDepartment of Surgery, Columbia University Medical Center, USA Department of Physiology, Maastricht University Medical Center, The Netherlands hugo@sondermeijer.net.
Piotr WitkowskiDepartment of Surgery, Columbia University Medical Center, USA Department of Surgery, Section of Transplantation, University of Chicago Medicine, USA.
David WoodlandDepartment of Surgery, Columbia University Medical Center, USA.
Tetsunori SekiDepartment of Surgery, Columbia University Medical Center, USA.
Frank J AangenendtDepartment of Mechanical Engineering, Eindhoven University of Technology, The Netherlands.
Arnoud van der LaarseDepartments of Cardiology and Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, The Netherlands.
Silviu ItescuDepartment of Surgery, Columbia University Medical Center, USA Mesoblast Limited, Melbourne, Australia.
Mark A HardyDepartment of Surgery, Columbia University Medical Center, USA.
Columbia University Irving Medical Center · USEindhoven University of Technology · NLLeiden University Medical Center · NLMaastricht University · NLUniversity of Chicago · US

Funding

POSTDOCTORAL TRAINING IN CARDIOVASCULAR DISEASET32HL007854 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Marwah Abdalla, Michael Argenziano · 1996 to 2026
$14.7M
Ventricular Assist Devices: Bleeding/Thrombosis &TherapyP50HL077096 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FINK, DANIEL · 2005 to 2008
$13.4M
NHLBI NIH HHS P50 HL077096NHLBI NIH HHS T32 HL007854
6 · The paper itself

Abstract

Sodium alginate is an effective biomaterial for tissue engineering applications. Non-purified alginate is contaminated with protein, lipopolysaccharide, DNA, and RNA, which could elicit adverse immunological reactions. We developed a purification protocol to generate biocompatible alginate based on (a) activated charcoal treatment, (b) use of hydrophobic membrane filtration (we used hydrophobic polyvinylidene difluoride membranes to remove organic contaminants), (c) dialysis, and finally (d) ethanol precipitation. Using this approach, we could omit pre-treatment with chloroform and significantly reduce the quantities of reagents used. Purification resulted in reduction of residual protein by 70% down to 0.315 mg/g, DNA by 62% down to 1.28 µg/g, and RNA by 61% down to less than 10 µg/g, respectively. Lipopolysaccharide levels were reduced by >90% to less than 125 EU/g. Purified alginate did not induce splenocyte proliferation in vitro. Three-dimensional scaffolds generated from purified alginate did not elicit a significant foreign body reaction, fibrotic overgrowth, or macrophage infiltration 4 weeks after implantation. This study describes a simplified and economical alginate purification method that results in alginate purity, which meets clinically useful criteria.

Indexed as

Absorption, PhysicochemicalAluminum CompoundsAnimalsBiocompatible MaterialsCharcoalChemical PrecipitationEthanolFluorocarbon PolymersForeign-Body ReactionImmunity, InnateMaleMaterials TestingMembranes, ArtificialPolyvinylsRatsRats, Inbred LewAluminum CompoundsBiocompatible MaterialsCharcoalEthanolFluorocarbon PolymersMembranes, Artificialpolyvinylidene fluoridePolyvinylssodium aluminum hydrideSodium CompoundsAlginatebioengineeringpurificationscaffoldstransplantation

Identifiers

PMID27114440
PMCPMC5479495
OpenAlexW2343275289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.